Cargando…

mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells

Age-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithe...

Descripción completa

Detalles Bibliográficos
Autores principales: Merle, David A., Provenzano, Francesca, Jarboui, Mohamed Ali, Kilger, Ellen, Clark, Simon J., Deleidi, Michela, Armento, Angela, Ueffing, Marius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750186/
https://www.ncbi.nlm.nih.gov/pubmed/34943047
http://dx.doi.org/10.3390/antiox10121944
_version_ 1784631404543344640
author Merle, David A.
Provenzano, Francesca
Jarboui, Mohamed Ali
Kilger, Ellen
Clark, Simon J.
Deleidi, Michela
Armento, Angela
Ueffing, Marius
author_facet Merle, David A.
Provenzano, Francesca
Jarboui, Mohamed Ali
Kilger, Ellen
Clark, Simon J.
Deleidi, Michela
Armento, Angela
Ueffing, Marius
author_sort Merle, David A.
collection PubMed
description Age-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithelium (RPE) with subsequent degeneration of photoreceptors in the retina. The alternative complement pathway is tightly linked to AMD. In particular, the genetic variant in the complement factor H gene (CFH), which leads to the Y402H polymorphism in the factor H protein (FH), confers the second highest risk for the development and progression of AMD. Although the association between the FH Y402H variant and increased complement system activation is known, recent studies have uncovered novel FH functions not tied to this activity and highlighted functional relevance for intracellular FH. In our previous studies, we show that loss of CFH expression in RPE cells causes profound disturbances in cellular metabolism, increases the vulnerability towards oxidative stress, and modulates the activation of pro-inflammatory signaling pathways, most importantly the NF-kB pathway. Here, we silenced CFH in hTERT-RPE1 cells to investigate the mechanism by which intracellular FH regulates RPE cell homeostasis. We found that silencing of CFH results in hyperactivation of mTOR signaling along with decreased mitochondrial respiration and that mTOR inhibition via rapamycin can partially rescue these metabolic defects. To obtain mechanistic insight into the function of intracellular FH in hTERT-RPE1 cells, we analyzed the interactome of FH via immunoprecipitation followed by mass spectrometry-based analysis. We found that FH interacts with essential components of the ubiquitin-proteasomal pathway (UPS) as well as with factors associated with RB1/E2F signalling in a complement-pathway independent manner. Moreover, we found that FH silencing affects mRNA levels of the E3 Ubiquitin-Protein Ligase Parkin and PTEN induced putative kinase (Pink1), both of which are associated with UPS. As inhibition of mTORC1 was previously shown to result in increased overall protein degradation via UPS and as FH mRNA and protein levels were shown to be affected by inhibition of UPS, our data stress a potential regulatory link between endogenous FH activity and the UPS.
format Online
Article
Text
id pubmed-8750186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87501862022-01-12 mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells Merle, David A. Provenzano, Francesca Jarboui, Mohamed Ali Kilger, Ellen Clark, Simon J. Deleidi, Michela Armento, Angela Ueffing, Marius Antioxidants (Basel) Article Age-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithelium (RPE) with subsequent degeneration of photoreceptors in the retina. The alternative complement pathway is tightly linked to AMD. In particular, the genetic variant in the complement factor H gene (CFH), which leads to the Y402H polymorphism in the factor H protein (FH), confers the second highest risk for the development and progression of AMD. Although the association between the FH Y402H variant and increased complement system activation is known, recent studies have uncovered novel FH functions not tied to this activity and highlighted functional relevance for intracellular FH. In our previous studies, we show that loss of CFH expression in RPE cells causes profound disturbances in cellular metabolism, increases the vulnerability towards oxidative stress, and modulates the activation of pro-inflammatory signaling pathways, most importantly the NF-kB pathway. Here, we silenced CFH in hTERT-RPE1 cells to investigate the mechanism by which intracellular FH regulates RPE cell homeostasis. We found that silencing of CFH results in hyperactivation of mTOR signaling along with decreased mitochondrial respiration and that mTOR inhibition via rapamycin can partially rescue these metabolic defects. To obtain mechanistic insight into the function of intracellular FH in hTERT-RPE1 cells, we analyzed the interactome of FH via immunoprecipitation followed by mass spectrometry-based analysis. We found that FH interacts with essential components of the ubiquitin-proteasomal pathway (UPS) as well as with factors associated with RB1/E2F signalling in a complement-pathway independent manner. Moreover, we found that FH silencing affects mRNA levels of the E3 Ubiquitin-Protein Ligase Parkin and PTEN induced putative kinase (Pink1), both of which are associated with UPS. As inhibition of mTORC1 was previously shown to result in increased overall protein degradation via UPS and as FH mRNA and protein levels were shown to be affected by inhibition of UPS, our data stress a potential regulatory link between endogenous FH activity and the UPS. MDPI 2021-12-03 /pmc/articles/PMC8750186/ /pubmed/34943047 http://dx.doi.org/10.3390/antiox10121944 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Merle, David A.
Provenzano, Francesca
Jarboui, Mohamed Ali
Kilger, Ellen
Clark, Simon J.
Deleidi, Michela
Armento, Angela
Ueffing, Marius
mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_full mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_fullStr mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_full_unstemmed mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_short mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_sort mtor inhibition via rapamycin treatment partially reverts the deficit in energy metabolism caused by fh loss in rpe cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750186/
https://www.ncbi.nlm.nih.gov/pubmed/34943047
http://dx.doi.org/10.3390/antiox10121944
work_keys_str_mv AT merledavida mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT provenzanofrancesca mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT jarbouimohamedali mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT kilgerellen mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT clarksimonj mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT deleidimichela mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT armentoangela mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT ueffingmarius mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells